15832-69-6Relevant articles and documents
A one-pot two-step synthesis of tertiary alcohols combining the biocatalytic laccase/TEMPO oxidation system with organolithium reagents in aerobic aqueous media at room temperature
Capriati, Vito,Cicco, Luciana,García-álvarez, Joaquín,González-Sabín, Javier,Lecuna, Ramón,Presa Soto, Alejandro,Ríos-Lombardía, Nicolás,Ramos-Martín, Marina,Vitale, Paola
supporting information, p. 13534 - 13537 (2021/12/23)
The one-pot/two-step combination of enzymes and polar organometallic chemistry in aqueous media is for the first time presented as a proof-of-concept study. The unprecedented combination of the catalytic oxidation of secondary alcohols by the system laccase/TEMPO with the ultrafast addition (3 s reaction time) of polar organometallic reagents (RLi/RMgX) to thein situformed ketones, run under air at room temperature, allows the straightforward and chemoselective synthesis of tertiary alcohols with broad substrate scope and excellent conversions (up to 96%).
Compound used as Bruton tyrosine kinase inhibitor, and preparation method and application of compound
-
Paragraph 0290; 0291; 0292; 0293, (2017/08/29)
The invention provides a compound with a structure shown as the formula (I), or an isomer, pharmaceutically acceptable solvate and salt thereof, which is used as the Bruton tyrosine kinase inhibitor. The Bruton tyrosine kinase inhibitor has higher inhibit
BTK INHIBITORS
-
Page/Page column 112, (2016/07/27)
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.